Cureus · 2026
Novel Galactosidase-Beta-1 Variant in Infantile GM1 Gangliosidosis: A Case Report.
Клинический случайСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Srivastava Preeti, Kumar Abhishek, Jain Shikhar Deep, Kumar Ratan, Swaroop Shikha, Sarangi Tapas
Аннотация
GM1 gangliosidosis is an autosomal recessive lysosomal storage disorder caused by pathogenic GLB1 variants that impair β-galactosidase activity, resulting in GM1 ganglioside accumulation. The infantile (type I) form is the most severe. We describe the case of a one-year-old girl born to consanguineous parents who presented with developmental regression, hypotonia, coarse facial features, hepatosplenomegaly, macular cherry-red spots, Mongolian spots, and sensorineural hearing loss. Whole-exome sequencing revealed a novel homozygous GLB1 variant, NM_000404.4:c.1525T>A (p.Trp509Arg), absent from population databases and predicted deleterious by in silico tools. According to the American College of Medical Genetics and Genomics guidelines, it is classified as a variant of uncertain significance, though the phenotype-genotype match suggests pathogenicity. This case broadens the GLB1 mutational spectrum and underscores the value of early genetic testing for diagnosis, counseling, and management.